BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 12368193)

  • 21. Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence.
    Papadogianni D; Soulitzis N; Delakas D; Spandidos DA
    Tumour Biol; 2014 Mar; 35(3):2481-9. PubMed ID: 24213852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unique domain functions of p63 isotypes that differentially regulate distinct aspects of epidermal homeostasis.
    King KE; Ponnamperuma RM; Gerdes MJ; Tokino T; Yamashita T; Baker CC; Weinberg WC
    Carcinogenesis; 2006 Jan; 27(1):53-63. PubMed ID: 16081516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired delta NP63 expression is associated with poor tumor development in transitional cell carcinoma of the bladder.
    He Y; Wu X; Tang W; Tian D; Luo C; Yin Z; Du H
    J Korean Med Sci; 2008 Oct; 23(5):825-32. PubMed ID: 18955789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.
    Barbareschi M; Pecciarini L; Cangi MG; Macrì E; Rizzo A; Viale G; Doglioni C
    Am J Surg Pathol; 2001 Aug; 25(8):1054-60. PubMed ID: 11474290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of p63 and p73 in tumor formation and progression: coming of age toward clinical usefulness. Commentary re: F. Koga et al., Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin. Cancer Res., 9: 5501-5507, 2003, and P. Puig et al., p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder Cancer. Clin. Cancer Res., 9: 5642-5651, 2003.
    Moll UM
    Clin Cancer Res; 2003 Nov; 9(15):5437-41. PubMed ID: 14654522
    [No Abstract]   [Full Text] [Related]  

  • 26. Differential expression of p63 isoforms in female reproductive organs.
    Kurita T; Cunha GR; Robboy SJ; Mills AA; Medina RT
    Mech Dev; 2005 Sep; 122(9):1043-55. PubMed ID: 15922574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression.
    Kim S; Han J; Kim J; Park C
    Cancer Res; 2004 Oct; 64(19):6900-5. PubMed ID: 15466179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 cases.
    Compérat E; Camparo P; Haus R; Chartier-Kastler E; Bart S; Delcourt A; Houlgatte A; François R; Capron F; Vieillefond A
    Virchows Arch; 2006 Mar; 448(3):319-24. PubMed ID: 16283378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential recognition of response elements determines target gene specificity for p53 and p63.
    Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
    Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p63 Coordinates anogenital modeling and epithelial cell differentiation in the developing female urogenital tract.
    Ince TA; Cviko AP; Quade BJ; Yang A; McKeon FD; Mutter GL; Crum CP
    Am J Pathol; 2002 Oct; 161(4):1111-7. PubMed ID: 12368184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p63 expression is associated with p53 loss in oral-esophageal epithelia of p53-deficient mice.
    Suliman Y; Opitz OG; Avadhani A; Burns TC; El-Deiry W; Wong DT; Rustgi AK
    Cancer Res; 2001 Sep; 61(17):6467-73. PubMed ID: 11522642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer.
    Puig P; Capodieci P; Drobnjak M; Verbel D; Prives C; Cordon-Cardo C; Di Como CJ
    Clin Cancer Res; 2003 Nov; 9(15):5642-51. PubMed ID: 14654547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.
    Yang A; Kaghad M; Wang Y; Gillett E; Fleming MD; Dötsch V; Andrews NC; Caput D; McKeon F
    Mol Cell; 1998 Sep; 2(3):305-16. PubMed ID: 9774969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the tumor suppressor protein 14-3-3 sigma is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial-to-mesenchymal transition.
    Moreira JM; Gromov P; Celis JE
    Mol Cell Proteomics; 2004 Apr; 3(4):410-9. PubMed ID: 14736829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development.
    Wu G; Nomoto S; Hoque MO; Dracheva T; Osada M; Lee CC; Dong SM; Guo Z; Benoit N; Cohen Y; Rechthand P; Califano J; Moon CS; Ratovitski E; Jen J; Sidransky D; Trink B
    Cancer Res; 2003 May; 63(10):2351-7. PubMed ID: 12750249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p63 is a prostate basal cell marker and is required for prostate development.
    Signoretti S; Waltregny D; Dilks J; Isaac B; Lin D; Garraway L; Yang A; Montironi R; McKeon F; Loda M
    Am J Pathol; 2000 Dec; 157(6):1769-75. PubMed ID: 11106548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p63 in laryngeal squamous cell carcinoma: evidence for a role of TA-p63 down-regulation in tumorigenesis and lack of prognostic implications of p63 immunoreactivity.
    Pruneri G; Pignataro L; Manzotti M; Carboni N; Ronchetti D; Neri A; Cesana BM; Viale G
    Lab Invest; 2002 Oct; 82(10):1327-34. PubMed ID: 12379767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alteration of the MDM2-p73-P14ARF pathway related to tumour progression during urinary bladder carcinogenesis.
    Schlott T; Quentin T; Korabiowska M; Budd B; Kunze E
    Int J Mol Med; 2004 Nov; 14(5):825-36. PubMed ID: 15492852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progressive loss of CD44 gene expression in invasive bladder cancer.
    Sugino T; Gorham H; Yoshida K; Bolodeoku J; Nargund V; Cranston D; Goodison S; Tarin D
    Am J Pathol; 1996 Sep; 149(3):873-82. PubMed ID: 8780391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 mutations in bladder carcinoma cell lines.
    Cooper MJ; Haluschak JJ; Johnson D; Schwartz S; Morrison LJ; Lippa M; Hatzivassiliou G; Tan J
    Oncol Res; 1994; 6(12):569-79. PubMed ID: 7787250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.